96 related articles for article (PubMed ID: 23607633)
21. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A
Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655
[TBL] [Abstract][Full Text] [Related]
22. FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.
Cohen MH; Gootenberg J; Keegan P; Pazdur R
Oncologist; 2007 Jun; 12(6):713-8. PubMed ID: 17602060
[TBL] [Abstract][Full Text] [Related]
23. Carboplatin and weekly paclitaxel in non-small cell lung cancer patients unfit for or pretreated with chemotherapy.
Numico G; Colantonio I; Gasco M; Bertelli G; Garrone O; Occelli M; Fea E; Di Costanzo G; Granetto C; Heouaine A; Russi E; Merlano M
Anticancer Res; 2005; 25(3c):2555-9. PubMed ID: 16080492
[TBL] [Abstract][Full Text] [Related]
24. Phase I study of paclitaxel as a 3-hour infusion followed by carboplatin in untreated patients with stage IV non-small cell lung cancer.
Rowinsky EK; Flood WA; Sartorius SE; Bowling MK; Wagner J; Ettinger DS
Semin Oncol; 1995 Aug; 22(4 Suppl 9):48-54. PubMed ID: 7644928
[TBL] [Abstract][Full Text] [Related]
25. Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer.
Natale RB
Semin Oncol; 1996 Oct; 23(5 Suppl 12):2-6. PubMed ID: 8941402
[TBL] [Abstract][Full Text] [Related]
26. A phase I study of carboplatin and paclitaxel in non-small cell lung cancer: a University of Colorado Cancer Center study.
Bunn PA; Kelly K
Semin Oncol; 1995 Aug; 22(4 Suppl 9):2-6. PubMed ID: 7644924
[TBL] [Abstract][Full Text] [Related]
27. [A retrospective study of carboplatin and weekly paclitaxel combination chemotherapy for elderly patients with advanced non-small cell lung cancer].
Mito A; Yamasaki M; Ohashi N; Kajihara T; Nitta T; Awaya H; Ikegami Y; Arita K
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1707-11. PubMed ID: 20841932
[TBL] [Abstract][Full Text] [Related]
28. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.
Herbst RS; Giaccone G; Schiller JH; Natale RB; Miller V; Manegold C; Scagliotti G; Rosell R; Oliff I; Reeves JA; Wolf MK; Krebs AD; Averbuch SD; Ochs JS; Grous J; Fandi A; Johnson DH
J Clin Oncol; 2004 Mar; 22(5):785-94. PubMed ID: 14990633
[TBL] [Abstract][Full Text] [Related]
29. The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias.
Minegishi Y; Sudoh J; Kuribayasi H; Mizutani H; Seike M; Azuma A; Yoshimura A; Kudoh S; Gemma A
Lung Cancer; 2011 Jan; 71(1):70-4. PubMed ID: 20493578
[TBL] [Abstract][Full Text] [Related]
30. Effects on the immune system and toxicity of carboplatin/paclitaxel combination chemotherapy in patients with stage III-IV ovarian and non small cell lung cancer and its role in survival and toxicity.
Hatziveis K; Tourlakis D; Hountis P; Kyriazanos I; Sougleri M; Ginopoulos P; Camoutsis C
J BUON; 2012; 17(1):143-8. PubMed ID: 22517709
[TBL] [Abstract][Full Text] [Related]
31. Factors affecting bone marrow toxicity following administration of carboplatin and paclitaxel in patients with non-small cell lung cancer.
Ganti AK; Loberiza FR; Kessinger A
Anticancer Res; 2010 Apr; 30(4):1365-9. PubMed ID: 20530454
[TBL] [Abstract][Full Text] [Related]
32. Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer.
Tell R; Sederholm C; Klintenberg C; Franksson L; Brandén E; Hillerdal G; Lönn U; Lindén CJ; Ewers SB; Lamberg K; Mrazek E; Lödén B; Sjögren A; Linné T; Friesland S; Sirzén F
Anticancer Res; 2008; 28(5B):2851-7. PubMed ID: 19031924
[TBL] [Abstract][Full Text] [Related]
33. Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel.
Socinski MA; Schell MJ; Bakri K; Peterman A; Lee JH; Unger P; Yates S; Hudgens S; Kies MS
Cancer; 2002 Sep; 95(6):1265-73. PubMed ID: 12216094
[TBL] [Abstract][Full Text] [Related]
34. Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.
Williamson SK; Crowley JJ; Lara PN; McCoy J; Lau DH; Tucker RW; Mills GM; Gandara DR;
J Clin Oncol; 2005 Dec; 23(36):9097-104. PubMed ID: 16361616
[TBL] [Abstract][Full Text] [Related]
35. A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial.
Ichiki M; Kawasaki M; Takayama K; Ninomiya K; Kuba M; Iwami F; Miyazaki N; Oishi K; Takeo S; Aizawa H; Nakanishi Y
Cancer Chemother Pharmacol; 2006 Sep; 58(3):368-73. PubMed ID: 16395589
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel and carboplatin in metastatic non-small cell lung cancer: preliminary results of a phase I study.
Belani CP; Aisner J; Hiponia D; Ramanathan R
Semin Oncol; 1996 Oct; 23(5 Suppl 12):19-21. PubMed ID: 8941406
[TBL] [Abstract][Full Text] [Related]
37. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Herbst RS; Hammond LA; Carbone DP; Tran HT; Holroyd KJ; Desai A; Williams JI; Bekele BN; Hait H; Allgood V; Solomon S; Schiller JH
Clin Cancer Res; 2003 Sep; 9(11):4108-15. PubMed ID: 14519633
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials.
DeVore RF; Jagasia M; Johnson DH
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-27-S12-29. PubMed ID: 9331116
[TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacology of carboplatin administered in combination with paclitaxel.
van Warmerdam LJ; Huizing MT; Giaccone G; Postmus PE; ten Bokkel Huinink WW; van Zandwijk N; Koolen MG; Helmerhorst TJ; van der Vijgh WJ; Veenhof CH; Beijnen JH
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-97-S2-104. PubMed ID: 9045347
[TBL] [Abstract][Full Text] [Related]
40. A phase II study directed by a clinical pathway for carboplatin and weekly paclitaxel in previously untreated patients with unresectable non-small cell lung cancer.
Komuta K; Osaki T; Mori M; Yokota S; Tanio Y; Matsui K; Imamura F; Kawase I
Chemotherapy; 2010; 56(1):39-45. PubMed ID: 20185914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]